Pricing Log in Create free account

Werewolf Therapeutics, Inc. (HOWL) vs Pliant Therapeutics, Inc. (PLRX)

Werewolf Therapeutics, Inc. and Pliant Therapeutics, Inc. are both Biotechnology companies. Werewolf Therapeutics, Inc. and Pliant Therapeutics, Inc. are of similar size ($50.5M and $49.6M). Werewolf Therapeutics, Inc. grew revenue faster over the last twelve months: −5.21% against −49.0%. Pliant Therapeutics, Inc. has the higher net margin (0.00% vs −141.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Pliant Therapeutics, Inc. leads on 9 and Werewolf Therapeutics, Inc. on 6.

Valuation

Metric HOWL PLRX Biotechnology median
P/E n/m n/m 10.60
P/S 1.99 9.98 9.40
P/B 2.98 0.34 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.81 0.66
EV/Sales 1.98 (15.42) 9.02
Earnings yield (73.00%) (183.95%) (32.88%)
Free cash flow yield (61.47%) (140.81%) (23.13%)

Profitability

Metric HOWL PLRX Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (128.18%) 0.00% 0.00%
Net margin (141.94%) 0.00% 0.00%
Free cash flow margin (122.51%) 0.00% 0.00%
Return on equity (119.86%) (50.29%) (51.96%)
Return on assets (59.31%) (37.69%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HOWL PLRX Biotechnology median
Revenue growth (TTM) (5.21%) (48.95%) 6.76%
EPS growth (last fiscal year) 18.40% 29.97% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HOWL PLRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.91 9.90 4.97
Net debt to EBITDA 0.97 1.27 1.01

Dividend

Metric HOWL PLRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HOWL PLRX Biotechnology median
Market cap 49.57m 50.52m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack